The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 49 | 21.8x | 20.1x | Near average | |
Growth | 60 | 39.3% | 5.6% | Near average | |
Quality | 66 | 25.3% | 7.6% | Near average | |
Safety | 80 | 0.2x | 0.4x | Above average | |
Capital Return | 46 | 0.52% | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Chemed Corporation is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Chemed Corporation shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Chemed stock shows a state of complete stability in analyst estimates during recent periods (1, 7, and 30 days), as the target price settled at 475 dollars without any significant adjustments. This consistency reflects the absence of new catalysts or substantial revisions by analysts, noting that only one analyst currently covers the stock according to available data, which eliminates any Dispersion in forecasts.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.